Enzyme cascade-induced optical sensing of hyaluronidase using an ultraviolet-modified liquid crystal interface
- PMID: 40897895
- DOI: 10.1007/s00604-025-07499-x
Enzyme cascade-induced optical sensing of hyaluronidase using an ultraviolet-modified liquid crystal interface
Abstract
H yaluronidase (HAase) is a clinically significant enzyme involved in tumor progression, extracellular matrix remodeling, and inflammation. Hence, HAase is an important biomarker for disease diagnostics. Here, a label-free, pH-responsive biosensor using ultraviolet (UV)-treated liquid crystals (LCs) for HAase detection is presented. The sensor utilizes a cascade enzymatic reaction where HAase hydrolyzes hyaluronic acid (HA) into oligosaccharides, which are sequentially degraded by β-glucuronidase, chitosanase, and amine oxidase into glucosaminic acid, hydrogen peroxide, and protons (H⁺). This results in a significant decrease in pH. The pH change alters the protonation state of the 4-cyano-4'-biphenylcarboxylic acid UV-induced product of 4-cyano-4'-pentylbiphenyl, triggering a distinct optical reorientation of the LC at the aqueous interface. Reorientation is evident as a dark-to-bright transition in polarized optical microscopy. The sensor is highly sensitive with a detection limit of 0.0018 U/mL and a linear detection range from 0.3 to 40 U/mL. The sensor also demonstrates excellent selectivity and can detect HAase in dilute human serum and urine samples, highlighting its potential as a practical diagnostic platform.
Keywords: Biosensor; Enzyme cascade; Hyaluronidase; Liquid crystals; pH sensing.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Indicator-Free Detection of Hyaluronidase Based on a Conductivity-Regulated Bipolar Electrochemiluminescence Platform.Anal Chem. 2025 Sep 2;97(34):18735-18741. doi: 10.1021/acs.analchem.5c03409. Epub 2025 Aug 19. Anal Chem. 2025. PMID: 40827572
-
Electrophoresis.2025 Jul 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36251838 Free Books & Documents.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets.Mol Biomed. 2025 Jul 12;6(1):50. doi: 10.1186/s43556-025-00299-y. Mol Biomed. 2025. PMID: 40646377 Free PMC article. Review.
-
Hyaluronidase for reducing perineal trauma.Cochrane Database Syst Rev. 2024 Nov 14;11(11):CD010441. doi: 10.1002/14651858.CD010441.pub3. Cochrane Database Syst Rev. 2024. PMID: 39540564
References
-
- Skarmoutsos I, Skarmoutsos A, Katafigiotis I, Tataki E, Giagini A, Adamakis I, Alamanis C, Duvdevani M, Sitaras N, Constantinides C (2018) Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer. Med Oncol 35:1–6. https://doi.org/10.1007/s12032-018-1157-9 - DOI
-
- Jayadev C, Rout R, Price A, Hulley P, Mahoney D (2012) Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms. J Immunol Methods 386:22–30. https://doi.org/10.1016/j.jim.2012.08.012 - DOI - PubMed
-
- Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, Lokeshwar VB (2003) Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. Cancer Res 63:2638–2644 - PubMed
-
- Meszaros M, Kis A, Kunos L, Tarnoki AD, Tarnoki DL, Lazar Z, Bikov A (2020) The role of hyaluronic acid and hyaluronidase-1 in obstructive sleep apnoea. Sci Rep 10:19484. https://doi.org/10.1038/s41598-020-74769-4 - DOI - PubMed - PMC
-
- Morera DS, Hennig MS, Talukder A, Lokeshwar SD, Wang J, Garcia-Roig M, Ortiz N, Yates TJ, Lopez LE, Kallifatidis G (2017) Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets. Br J Cancer 117:1507–1517. https://doi.org/10.1038/bjc.2017.318 - DOI - PubMed - PMC